Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer
- VernacularTitle:拓扑替康联合顺铂治疗卵巢上皮性癌的临床研究
- Author:
Li-Hua MENG
;
Bei-Hua KONG
;
You-Zhong ZHANG
;
Xing-Sheng YANG
;
Li-Jie WANG
;
Shi-Li SU
;
Jie JIANG
;
Bao-Xia CUI
;
Bo WANG
- Publication Type:Journal Article
- Keywords:
Ovarian neoplasms;
Topotecan;
Cisplatin;
Antineoplastic combined chemotherapy protocols
- From:
Chinese Journal of Obstetrics and Gynecology
2000;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).(4) Toxicity:Grade Ⅲ-Ⅳ myelosuppression was 60%(18/30)in Tp group,26%(8/31)in TC group and 30%(10/33)in PC group.The TP regimen had the greatest hematologic toxicity(P0.05). Conclusions As first line chemotherapy in epithelial ovarian cancer,TP regimen comparable to the standard chemotherapy regimen.
